MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    Taekwondo Training with External Focus of Attention as a Complex Motor Intervention in Parkinson’s Disease: A Pilot Study

    B. Kim, M. Torbitt, J. Lombardi, A. Deblois (Syracuse, USA)

    Objective: To examine the feasibility and effects of an 8-week Taekwondo (TKD) training emphasizing multidirectional, externally focused, and cognitively challenging motor training on balance and mobility in people with Parkinson’s disease (PwPD). Background: Conventional…
  • 2026 International Congress

    Machine Learning–Based Brain Age Modeling Reveals Accelerated Structural Degeneration in Parkinson’s Disease

    ZK. Liu, BX. Liu, MJ. Fang, N. Zhou, RT. Li, LC. He, ZT. Hu, WH. Li (Beijing, China)

    Objective: To compare the rate of global brain structural degeneration between healthy controls (HC) and patients with Parkinson’s disease (PD). Background: Normal aging is accompanied…
  • 2026 International Congress

    Prevalence and associated factors of sarcopenia among Thai patients with ambulatory Parkinson’s disease

    J. Intum, P. Lolekha, K. Chupisanyarote (Khlong Luang, Thailand)

    Objective: Objectives: To determine the prevalence of Asian Working Group for Sarcopenia (AWGS) 2019-defined sarcopenia phenotypes, identify associated factors, and evaluate screening performance in Thai PD patients. Background: Sarcopenia is…
  • 2026 International Congress

    MDS-UPDRS Part III Cannot Be Reliably Reduced for Prognostic Modeling in Early Parkinson’s Disease

    M. Alam, G. Stebbins, T. Mestre, C. Goetz, S. Luo (Durham, USA)

    Objective: To determine whether subsets of MDS-UPDRS Part III items have equal or better prognostic value than the full scale for initiation of dopaminergic therapy…
  • 2026 International Congress

    Pesticide Exposure and Motor Severity in Parkinson’s Disease in a Mexican Population: A Retrospective Longitudinal Cohort Study

    J. Espinoza-Solares, A. Tapia, L. Cortés, J. López-Moreno, A. Cervantes-Arriaga, M. Rodriguez-Violante (Ciudad de México, Mexico)

    Objective: To evaluate whether pesticide exposure is associated with greater baseline motor severity and accelerated longitudinal motor progression in Mexican patients with Parkinson’s disease (PD).…
  • 2026 International Congress

    Clinical and Psychophysiological Characteristics of Chronic Pain in Parkinson’s Disease: Pain Phenotypes, Central Sensitization, and Quality of Life

    B. Alieva, Y. Shpilyukova (Moscow, Russian Federation)

    Objective: To assess clinical characteristics and pain phenotypes in PD patients with different types of chronic pain, to assess the severity of central sensitization and…
  • 2026 International Congress

    Can Voice Therapy Improve Swallowing in Advanced Parkinson’s Disease? A Comparison of SPEAK OUT!® Outcomes in Patients With Deep Brain Stimulation and Medical Therapy

    N. Likhitwitayawuid, S. Jitwiriyanont, K. Nantanukul, R. Bhidayasiri, O. Phokaewvarangkul (Bangkok, Thailand)

    Objective: To evaluate a 12-session SPEAK OUT!® program's effects on swallowing in advanced PD, comparing outcomes between medication-only and DBS-treated patients. Background: Oropharyngeal dysphagia is…
  • 2026 International Congress

    Preservation of Cognition Following Intravenous Mesenchymal Stem Cell Therapy in Parkinson’s Disease: Secondary Analysis of a Randomized Trial

    J. Martinez-Lemus, T. Thomas, C. Green, T. Ellmore, F. Triolo, S. Olson, J. Suescun, E. Tharp, C. Onuigbo, R. Ritter Iii, M. Schiess (Houston, USA)

    Objective: To evaluate longitudinal changes in global cognition following intravenous allogeneic bone marrow–derived mesenchymal stem cell (allo-hBM-MSC) therapy in Parkinson’s disease (PD). Background: Cognitive impairment…
  • 2026 International Congress

    A Case Report: Optimising Motor and Non-Motor Control in Advanced Parkinson’s Disease: The Role of Foslevodopa/Foscarbidopa After Deep Brain Stimulation

    J. Wong, S. Williams, M. Lubomski (St Leonards, Australia)

    Objective: To investigate the combined use of continuous subcutaneous foslevodopa/foscarbidopa and deep-brain stimulation in managing advanced Parkinsons Disease. Background: Continuous foslevodopa/foscarbidopa subcutaneous (SC) infusion has been shown…
  • 2026 International Congress

    Virtual Reality–Based Rehabilitation for Freezing of Gait in Parkinson’s Disease: Implications for Cognitive–Motor Integration: A Systematic Review

    W. Phuenpathom, R. Bhidayasiri, S. Lewis (Sydney, Australia)

    Objective: To evaluate the effects of VR-based rehabilitation on freezing of gait and gait performance in individuals with PD and FOG. Background: Freezing of gait…
  • « Previous Page
  • 1
  • …
  • 88
  • 89
  • 90
  • 91
  • 92
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley